← Leaderboards
Mitzi Nagarkatti
Virginia Commonwealth University
$16,087,844
Attributed
$21,247,573
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,700,167 · 20
VA$0 · 2
By mechanism
R01$16,917,072 · 9
P20$12,103,490 · 7
P30$2,232,366 · 1
P01$1,715,285 · 1
G20$441,954 · 1
R21$290,000 · 1
Top collaborators
- Prakash S. Nagarkatti33 shared
- Philip Brandon Busbee2 shared
- Melissa Ellermann2 shared
- Jason L Kubinak2 shared
- Jie Li2 shared
- Carole A Oskeritzian1 shared
- Kandy T Velazquez1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Prakash S. Nagarkatti$24,802,981
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationCellsPlayEpigenetic ProcessT-LymphocyteMediatingGenesRegulationPreventT Cell DifferentiationInflammatoryMicrornasTranscription FactorPathway InteractionsLeadDna MethylationImmunoregulationAffectEpigenetic RegulationRegulatory T-LymphocyteAryl Hydrocarbon Receptor LigandAutoimmune DiseasesGene ExpressionBase
Grant awards (84)
Center for Dietary Supplements and Inflammation (CDSI) COBRE$1,116,183
P30 · FY2025 · GM
Role of the environmental sensor, AhR on colitis$489,036
R01 · FY2025 · AI
Center for Dietary Supplements and Inflammation (CDSI) COBRE$1,116,183
P30 · FY2024 · GM
Role of the environmental sensor, AhR on colitis$491,569
R01 · FY2024 · AI
Role of the environmental sensor, AhR on colitis$53,717
R01 · FY2024 · AI
Role of the environmental sensor, AhR on colitis$494,400
R01 · FY2023 · AI
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant$481,157
R01 · FY2023 · ES · contact PI
Role of the environmental sensor, AhR on colitis$53,716
R01 · FY2023 · AI
Role of the environmental sensor, AhR on colitis$36,305
R01 · FY2023 · AI
Dietary Supplements and Inflammation Phase-2$1,949,670
P20 · FY2022 · GM
Role of the environmental sensor, AhR on colitis$497,231
R01 · FY2022 · AI
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant$484,774
R01 · FY2022 · ES · contact PI
Silybin as an anti-inflammatory and anti-fibrotic agent in cancer cachexia$178,619
P20 · FY2022 · GM
Targeting early ceramide elevation in pre-symptomatic eczema$178,619
P20 · FY2022 · GM
Gut microbial metabolites sulfonolipids mediate high fat diet-induced intestinal inflammation$159,764
P20 · FY2022 · GM
Cannabinoid signaling via the host CB1 receptor promotes intestinal dysbiosis$159,764
P20 · FY2022 · GM
Dietary Supplements and Inflammation Phase-2$1,972,295
P20 · FY2021 · GM
Role of the environmental sensor, AhR on colitis$499,913
R01 · FY2021 · AI
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant$488,319
R01 · FY2021 · ES · contact PI
Epigenetic Mechanisms of T Cell Dysregulation in PTSD$470,863
R01 · FY2021 · AI · contact PI
AhR ligands in epigenetic dysregulation of T cells$435,108
R01 · FY2021 · AI · contact PI
Dietary Supplements and Inflammation Phase-2: ACQUISITION OF A MULTIPARAMETER FLOW CYTOMETER$250,000
P20 · FY2021 · GM
Role and Regulation of the AhR-IL22 axis in I3C-mediated protection against colitis$226,106
P20 · FY2021 · GM
Altered Bacterial Bile Acid Metabolism as a Driver of CVID Enteropathy$203,080
P20 · FY2021 · GM
Cannabinoid signaling via the host CB1 receptor promotes intestinal dysbiosis$179,339
P20 · FY2021 · GM
Gut microbial metabolites sulfonolipids mediate high fat diet-induced intestinal inflammation$179,339
P20 · FY2021 · GM
Dietary Supplements and Inflammation Phase-2$1,994,479
P20 · FY2020 · GM
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant$499,393
R01 · FY2020 · ES · contact PI
Epigenetic Mechanisms of T Cell Dysregulation in PTSD$470,863
R01 · FY2020 · AI · contact PI
AhR ligands in epigenetic dysregulation of T cells$333,750
R01 · FY2020 · AI · contact PI
Role and Regulation of the AhR-IL22 axis in I3C-mediated protection against colitis$223,066
P20 · FY2020 · GM
Altered Bacterial Bile Acid Metabolism as a Driver of CVID Enteropathy$195,566
P20 · FY2020 · GM
AhR ligands in epigenetic dysregulation of T cells$45,745
R01 · FY2020 · AI · contact PI
AhR ligands in epigenetic dysregulation of T cells$30,763
R01 · FY2020 · AI · contact PI
Dietary Supplements and Inflammation Phase-2$2,016,232
P20 · FY2019 · GM
Epigenetic mechanisms in Transgenerational Effects of an Environmental Pollutant$500,283
R01 · FY2019 · ES · contact PI
Epigenetic Mechanisms of T Cell Dysregulation in PTSD$470,863
R01 · FY2019 · AI · contact PI
AhR ligands in epigenetic dysregulation of T cells$333,750
R01 · FY2019 · AI · contact PI
Dietary Supplements and Inflammation Phase-2$2,037,552
P20 · FY2018 · GM
Epigenetic Mechanisms of T Cell Dysregulation in PTSD$474,668
R01 · FY2018 · AI · contact PI
Indole-mediated epigenetic regulation of T cells in colitis$339,445
P01 · FY2018 · AT · contact PI
AhR ligands in epigenetic dysregulation of T cells$333,750
R01 · FY2018 · AI · contact PI
Epigenetic Mechanisms of T Cell Dysregulation in PTSD$483,807
R01 · FY2017 · AI · contact PI
Indole-mediated epigenetic regulation of T cells in colitis$355,017
P01 · FY2017 · AT · contact PI
AhR ligands in epigenetic dysregulation of T cells$333,750
R01 · FY2017 · AI · contact PI
Indole-mediated epigenetic regulation of T cells in colitis$353,624
P01 · FY2016 · AT · contact PI
Role of natural indoles in experimental autoimmune encephalomyelitis$386,789
R01 · FY2015 · AT · contact PI
Indole-mediated epigenetic regulation of T cells in colitis$328,583
P01 · FY2015 · AT · contact PI
Acquisition of the Next Generation Sequencer$0
IS1 · FY2015 · VA · contact PI
Role of CD44 in experimental Multiple Sclerosis$0
I01 · FY2015 · VA · contact PI
Role of natural indoles in experimental autoimmune encephalomyelitis$386,787
R01 · FY2014 · AT · contact PI
Indole-mediated epigenetic regulation of T cells in colitis$338,616
P01 · FY2014 · AT · contact PI
Estrogen-T cell Interactions$302,117
R01 · FY2014 · ES
Role of CD44 in experimental Multiple Sclerosis$0
I01 · FY2014 · VA · contact PI
Role of natural indoles in experimental autoimmune encephalomyelitis$386,788
R01 · FY2013 · AT · contact PI
Estrogen-T cell Interactions$299,064
R01 · FY2013 · ES
Role of CD44 in experimental Multiple Sclerosis$0
I01 · FY2013 · VA · contact PI
Role of natural indoles in experimental autoimmune encephalomyelitis$398,751
R01 · FY2012 · AT · contact PI
Estrogen-T cell Interactions$305,168
R01 · FY2012 · ES
Role of CD44 in experimental Multiple Sclerosis$0
I01 · FY2012 · VA · contact PI
Role of natural indoles in experimental autoimmune encephalomyelitis$411,000
R01 · FY2011 · AT · contact PI
Estrogen-T cell Interactions$305,168
R01 · FY2011 · ES
Estrogen-T cell Interactions$308,250
R01 · FY2010 · ES
Animal Facilities Improvement at USC$441,954
G20 · FY2008 · RR · contact PI
Cytotoxic lymphocytes in acute lung injury$297,188
R01 · FY2008 · AI · contact PI
Cytotoxic lymphocytes in acute lung injury$302,943
R01 · FY2007 · AI · contact PI
Role of CD44 in EC injury and melanoma therapy$275,764
R01 · FY2007 · AI · contact PI
Cytotoxic lymphocytes in acute lung injury$311,991
R01 · FY2006 · AI · contact PI
Endothelial cell injury by cytolytic lymphocytes$230,680
R01 · FY2006 · HL · contact PI
Role of CD44 in EC injury and melanoma therapy$227,200
R01 · FY2006 · AI · contact PI
Cytotoxic lymphocytes in acute lung injury$226,359
R01 · FY2005 · AI
Endothelial cell injury by cytolytic lymphocytes$210,527
R01 · FY2005 · HL
Role of CD44 in EC injury and melanoma therapy$193,469
R01 · FY2005 · AI
Role of CD44 in EC injury and melanoma therapy$100,850
R01 · FY2005 · AI
Cytotoxic lymphocytes in acute lung injury$81,858
R01 · FY2005 · AI
Endothelial cell injury by cytolytic lymphocytes$43,320
R01 · FY2005 · HL
Cytotoxic lymphocytes in acute lung injury$329,500
R01 · FY2004 · AI
Role of CD44 in EC injury and melanoma therapy$300,000
R01 · FY2004 · AI
Endothelial cell injury by cytolytic lymphocytes$254,180
R01 · FY2004 · HL
Role of CD44 in EC injury and melanoma therapy$300,000
R01 · FY2003 · AI
Endothelial cell injury by cytolytic lymphocytes$254,500
R01 · FY2003 · HL
Cannabinoid-induced apoptosis of immune cells$145,000
R21 · FY2002 · DA
Cannabinoid-induced apoptosis of immune cells$145,000
R21 · FY2001 · DA
ENDOTHELIAL CELL INJURY BY CYTOLYTIC LYMPHOCYTES$199,368
R01 · FY2000 · HL